Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Cancer & Clinical Oncology|April 1, 1986
Detection of cytotoxicity of freshly obtained lymphocytes and of lymphocytes activated with recombinant interleukin II (rIL-2) against lung cancer cell lines by human tumor clonogenic assay (HTCA)J Fujita, N Saijo, Y Sasaki, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacerM Miura, M Takeda, T Sasaki, et al.
Japanese Journal of Clinical Oncology|March 1, 1987
Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell linesW S Hong, J R Jett, Y Sasaki, et al.
The Tohoku Journal of Experimental Medicine|August 1, 1992
Treatment results by uneven fractionated irradiation, low-dose rate telecobalt therapy as a boost, and intraoperative irradiation for malignant gliomaS Yamada, Y Takai, K Nemoto, et al.
The Tohoku Journal of Experimental Medicine|May 1, 1992
Radioresponse and prognosis of malignant gliomaS Yamada, Y Takai, K Nemoto, et al.
International Journal of Oncology|May 18, 2011
Intraoperative radiation-therapy combined with hyperthermia for pancreatic-carcinomaS Yamada, Y Takai, K Nemoto, et al.
Cancer Treatment Reports|April 1, 1983
Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lungN Saijo, E Shimizu, K Eguchi, et al.
Japanese Journal of Clinical Oncology|December 1, 1984
Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumorsE Shimizu, N Saijo, K Eguchi, et al.
Japanese Journal of Clinical Oncology|March 1, 1985
Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumorsT Shinkai, N Saijo, K Tominaga, et al.
Japanese Journal of Clinical Oncology|June 1, 1986
Phase II study of mitoxantrone in patients with non-small cell lung cancerJ Suga, N Saijo, T Shinkai, et al.
Pageof 18